APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stem Cells

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

Selected research

Market Analysis & Forecast

Global Stem Cells Market Analysis and Forecast 2026-2032

1 January 2026204 pages

Choose your research edition.

Industry ResearchStem Cells Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Stem Cells Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Stem Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stem Cells Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Stem Cells Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.

Report Includes

Read the full market overview

This report presents an overview of global market for Stem Cells, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Stem Cells, also provides the revenue of main regions and countries. Of the upcoming market potential for Stem Cells, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Stem Cells revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Stem Cells market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Stem Cells revenue, projected growth trends, production technology, application and end-user industry.

Stem Cells Segment by Company

Osiris Therapeutics

NuVasive

Chiesi Pharmaceuticals

Medi-post

JCR Pharmaceutical

MolMed

Pharmicell

Anterogen

Takeda (TiGenix)

CBR

ViaCord

Esperite

LifeCell

CCBC

VCANBIO

BOYA LIFE

Beike Biotechnology

International Medical

Stem Cells Segment by Type

Stem Cell Storage

Stem Cell Pharmaceutical and Treatment

Stem Cells Segment by Application

Diseases of the Central Nervous System

Cardiovascular Disease

Diabetes

Cancer

Genetic Diseases

Autoimmune Disease

Bone and Cartilage Repair

Other

Stem Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Stem Cells in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Stem Cells company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cells revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Stem Cells Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stem Cell Storage Major Player Table 3. Stem Cell Pharmaceutical and Treatment Major Player Table 4. Global Stem Cells Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Diseases of the Central Nervous System Major Player Table 6. Cardiovascular Disease Major Player Table 7. Diabetes Major Player Table 8. Cancer Major Player Table 9. Genetic Diseases Major Player Table 10. Autoimmune Disease Major Player Table 11. Bone and Cartilage Repair Major Player Table 12. Other Major Player Table 13. Stem Cells Industry Trends Table 14. Stem Cells Industry Drivers Table 15. Stem Cells Industry Opportunities and Challenges Table 16. Stem Cells Industry Restraints Table 17. Global Stem Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Stem Cells Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Stem Cells Market Share by Region (2021-2026) Table 20. Global Stem Cells Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Stem Cells Market Share by Region (2027-2032) Table 22. Global Stem Cells Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Stem Cells Revenue Market Share by Players (2021-2026) Table 24. Global Stem Cells Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Stem Cells Key Players Headquarters & Area Served Table 26. Global Stem Cells Players, Product Type & Application Table 27. Global Stem Cells Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Stem Cells by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Stem Cells Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Stem Cells Revenue Market Share by Type (2021-2026) Table 34. Global Stem Cells Revenue Market Share by Type (2027-2032) Table 35. Global Stem Cells Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Stem Cells Revenue Market Share by Application (2021-2026) Table 39. Global Stem Cells Revenue Market Share by Application (2027-2032) Table 40. Osiris Therapeutics Company Information Table 41. Osiris Therapeutics Business Overview Table 42. Osiris Therapeutics Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Osiris Therapeutics Stem Cells Product Portfolio Table 44. Osiris Therapeutics Recent Development Table 45. NuVasive Company Information Table 46. NuVasive Business Overview Table 47. NuVasive Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. NuVasive Stem Cells Product Portfolio Table 49. NuVasive Recent Development Table 50. Chiesi Pharmaceuticals Company Information Table 51. Chiesi Pharmaceuticals Business Overview Table 52. Chiesi Pharmaceuticals Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Chiesi Pharmaceuticals Stem Cells Product Portfolio Table 54. Chiesi Pharmaceuticals Recent Development Table 55. Medi-post Company Information Table 56. Medi-post Business Overview Table 57. Medi-post Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Medi-post Stem Cells Product Portfolio Table 59. Medi-post Recent Development Table 60. JCR Pharmaceutical Company Information Table 61. JCR Pharmaceutical Business Overview Table 62. JCR Pharmaceutical Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. JCR Pharmaceutical Stem Cells Product Portfolio Table 64. JCR Pharmaceutical Recent Development Table 65. MolMed Company Information Table 66. MolMed Business Overview Table 67. MolMed Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. MolMed Stem Cells Product Portfolio Table 69. MolMed Recent Development Table 70. Pharmicell Company Information Table 71. Pharmicell Business Overview Table 72. Pharmicell Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Pharmicell Stem Cells Product Portfolio Table 74. Pharmicell Recent Development Table 75. Anterogen Company Information Table 76. Anterogen Business Overview Table 77. Anterogen Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Anterogen Stem Cells Product Portfolio Table 79. Anterogen Recent Development Table 80. Takeda (TiGenix) Company Information Table 81. Takeda (TiGenix) Business Overview Table 82. Takeda (TiGenix) Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Takeda (TiGenix) Stem Cells Product Portfolio Table 84. Takeda (TiGenix) Recent Development Table 85. CBR Company Information Table 86. CBR Business Overview Table 87. CBR Stem Cells Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. CBR Stem Cells Product Portfolio Table 89. CBR Recent Development Table 90. ViaCord Company Information Table 91. ViaCord Business Overview Table 92. ViaCord Stem Cells Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. ViaCord Stem Cells Product Portfolio Table 94. ViaCord Recent Development Table 95. Esperite Company Information Table 96. Esperite Business Overview Table 97. Esperite Stem Cells Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Esperite Stem Cells Product Portfolio Table 99. Esperite Recent Development Table 100. LifeCell Company Information Table 101. LifeCell Business Overview Table 102. LifeCell Stem Cells Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. LifeCell Stem Cells Product Portfolio Table 104. LifeCell Recent Development Table 105. CCBC Company Information Table 106. CCBC Business Overview Table 107. CCBC Stem Cells Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. CCBC Stem Cells Product Portfolio Table 109. CCBC Recent Development Table 110. VCANBIO Company Information Table 111. VCANBIO Business Overview Table 112. VCANBIO Stem Cells Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. VCANBIO Stem Cells Product Portfolio Table 114. VCANBIO Recent Development Table 115. BOYA LIFE Company Information Table 116. BOYA LIFE Business Overview Table 117. BOYA LIFE Stem Cells Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. BOYA LIFE Stem Cells Product Portfolio Table 119. BOYA LIFE Recent Development Table 120. Beike Biotechnology Company Information Table 121. Beike Biotechnology Business Overview Table 122. Beike Biotechnology Stem Cells Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Beike Biotechnology Stem Cells Product Portfolio Table 124. Beike Biotechnology Recent Development Table 125. International Medical Company Information Table 126. International Medical Business Overview Table 127. International Medical Stem Cells Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. International Medical Stem Cells Product Portfolio Table 129. International Medical Recent Development Table 130. North America Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Stem Cells Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Stem Cells Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Stem Cells Revenue by Country (US$ Million) & (2027-2032) Table 137. Europe Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe Stem Cells Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Stem Cells Revenue by Country (2021-2026) & (US$ Million) Table 143. Europe Stem Cells Revenue by Country (US$ Million) & (2027-2032) Table 144. China Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 145. China Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 146. China Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 147. China Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 149. Asia Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 150. Asia Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Stem Cells Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Stem Cells Revenue by Region (US$ Million) & (2021-2026) Table 154. Asia Stem Cells Revenue by Region (US$ Million) & (2027-2032) Table 155. SAMEA Stem Cells Revenue by Type (2021-2026) & (US$ Million) Table 156. SAMEA Stem Cells Revenue by Type (2027-2032) & (US$ Million) Table 157. SAMEA Stem Cells Revenue by Application (2021-2026) & (US$ Million) Table 158. SAMEA Stem Cells Revenue by Application (2027-2032) & (US$ Million) Table 159. SAMEA Stem Cells Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. SAMEA Stem Cells Revenue by Country (2021-2026) & (US$ Million) Table 161. SAMEA Stem Cells Revenue by Country (US$ Million) & (2027-2032) Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Stem Cells Image Figure 2. Global Stem Cells Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Stem Cells Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stem Cell Storage Image Figure 5. Stem Cell Pharmaceutical and Treatment Image Figure 6. Global Stem Cells Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Stem Cells Market Size Share 2021 VS 2025 VS 2032 Figure 8. Diseases of the Central Nervous System Image Figure 9. Cardiovascular Disease Image Figure 10. Diabetes Image Figure 11. Cancer Image Figure 12. Genetic Diseases Image Figure 13. Autoimmune Disease Image Figure 14. Bone and Cartilage Repair Image Figure 15. Other Image Figure 16. Global Stem Cells Market Size (US$ Million) & (2021-2032) Figure 17. Global Stem Cells Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Stem Cells Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Stem Cells Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Stem Cells Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Stem Cells Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Stem Cells Revenue Market Share by Type (2021-2032) Figure 24. Global Stem Cells Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Stem Cells Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Stem Cells Revenue Market Share by Application (2021-2032) Figure 27. North America Stem Cells Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Stem Cells Revenue Share by Type (2021-2032) Figure 29. North America Stem Cells Revenue Share by Application (2021-2032) Figure 30. North America Stem Cells Revenue Share by Country (2021-2032) Figure 31. United States Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Stem Cells Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Stem Cells Revenue Share by Type (2021-2032) Figure 36. Europe Stem Cells Revenue Share by Application (2021-2032) Figure 37. Europe Stem Cells Revenue Share by Country (2021-2032) Figure 38. Germany Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Stem Cells Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Stem Cells Revenue Share by Type (2021-2032) Figure 48. China Stem Cells Revenue Share by Application (2021-2032) Figure 49. Asia Stem Cells Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Stem Cells Revenue Share by Type (2021-2032) Figure 51. Asia Stem Cells Revenue Share by Application (2021-2032) Figure 52. Asia Stem Cells Revenue Share by Region (2021-2032) Figure 53. Japan Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Stem Cells Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Stem Cells Revenue Share by Type (2021-2032) Figure 61. SAMEA Stem Cells Revenue Share by Application (2021-2032) Figure 62. SAMEA Stem Cells Revenue Share by Country (2021-2032) Figure 63. Brazil Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Stem Cells Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cell Storage
  • Stem Cell Pharmaceutical and Treatment
Applications
  • Diseases of the Central Nervous System
  • Cardiovascular Disease
  • Diabetes
  • Cancer
  • Genetic Diseases
  • Autoimmune Disease
  • Bone and Cartilage Repair
  • Other
Companies covered
  • Osiris Therapeutics
  • NuVasive
  • Chiesi Pharmaceuticals
  • Medi-post
  • JCR Pharmaceutical
  • MolMed
  • Pharmicell
  • Anterogen
  • Takeda (TiGenix)
  • CBR
  • ViaCord
  • Esperite
  • LifeCell
  • CCBC
  • VCANBIO
  • BOYA LIFE
  • Beike Biotechnology
  • International Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Stem Cells Market by Type
  3. 1.2.1 Global Stem Cells Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stem Cell Storage
  5. 1.2.3 Stem Cell Pharmaceutical and Treatment
  6. 1.3 Stem Cells Market by Application
  7. 1.3.1 Global Stem Cells Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Diseases of the Central Nervous System
  9. 1.3.3 Cardiovascular Disease
  10. 1.3.4 Diabetes
  11. 1.3.5 Cancer
  12. 1.3.6 Genetic Diseases
  13. 1.3.7 Autoimmune Disease
  14. 1.3.8 Bone and Cartilage Repair
  15. 1.3.9 Other
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Stem Cells Market Dynamics
  1. 2.1 Stem Cells Industry Trends
  2. 2.2 Stem Cells Industry Drivers
  3. 2.3 Stem Cells Industry Opportunities and Challenges
  4. 2.4 Stem Cells Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Stem Cells Market Perspective (2021-2032)
  2. 3.2 Global Stem Cells Growth Trends by Region
  3. 3.2.1 Global Stem Cells Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Stem Cells Market Size by Region (2021-2026)
  5. 3.2.3 Global Stem Cells Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Stem Cells Revenue by Players
  2. 4.1.1 Global Stem Cells Revenue by Players (2021-2026)
  3. 4.1.2 Global Stem Cells Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Stem Cells Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Stem Cells Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Stem Cells Key Players Headquarters & Area Served
  7. 4.4 Global Stem Cells Players, Product Type & Application
  8. 4.5 Global Stem Cells Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Stem Cells Market CR5 and HHI
  11. 4.6.3 2025 Stem Cells Tier 1, Tier 2, and Tier 3
5 Stem Cells Market Size by Type
  1. 5.1 Global Stem Cells Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Stem Cells Revenue by Type (2021-2032)
  3. 5.3 Global Stem Cells Revenue Market Share by Type (2021-2032)
6 Stem Cells Market Size by Application
  1. 6.1 Global Stem Cells Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Stem Cells Revenue by Application (2021-2032)
  3. 6.3 Global Stem Cells Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Osiris Therapeutics
  2. 7.1.1 Osiris Therapeutics Company Information
  3. 7.1.2 Osiris Therapeutics Business Overview
  4. 7.1.3 Osiris Therapeutics Stem Cells Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Osiris Therapeutics Stem Cells Product Portfolio
  6. 7.1.5 Osiris Therapeutics Recent Developments
  7. 7.2 NuVasive
  8. 7.2.1 NuVasive Company Information
  9. 7.2.2 NuVasive Business Overview
  10. 7.2.3 NuVasive Stem Cells Revenue and Gross Margin (2021-2026)
  11. 7.2.4 NuVasive Stem Cells Product Portfolio
  12. 7.2.5 NuVasive Recent Developments
  13. 7.3 Chiesi Pharmaceuticals
  14. 7.3.1 Chiesi Pharmaceuticals Company Information
  15. 7.3.2 Chiesi Pharmaceuticals Business Overview
  16. 7.3.3 Chiesi Pharmaceuticals Stem Cells Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Chiesi Pharmaceuticals Stem Cells Product Portfolio
  18. 7.3.5 Chiesi Pharmaceuticals Recent Developments
  19. 7.4 Medi-post
  20. 7.4.1 Medi-post Company Information
  21. 7.4.2 Medi-post Business Overview
  22. 7.4.3 Medi-post Stem Cells Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Medi-post Stem Cells Product Portfolio
  24. 7.4.5 Medi-post Recent Developments
  25. 7.5 JCR Pharmaceutical
  26. 7.5.1 JCR Pharmaceutical Company Information
  27. 7.5.2 JCR Pharmaceutical Business Overview
  28. 7.5.3 JCR Pharmaceutical Stem Cells Revenue and Gross Margin (2021-2026)
  29. 7.5.4 JCR Pharmaceutical Stem Cells Product Portfolio
  30. 7.5.5 JCR Pharmaceutical Recent Developments
  31. 7.6 MolMed
  32. 7.6.1 MolMed Company Information
  33. 7.6.2 MolMed Business Overview
  34. 7.6.3 MolMed Stem Cells Revenue and Gross Margin (2021-2026)
  35. 7.6.4 MolMed Stem Cells Product Portfolio
  36. 7.6.5 MolMed Recent Developments
  37. 7.7 Pharmicell
  38. 7.7.1 Pharmicell Company Information
  39. 7.7.2 Pharmicell Business Overview
  40. 7.7.3 Pharmicell Stem Cells Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pharmicell Stem Cells Product Portfolio
  42. 7.7.5 Pharmicell Recent Developments
  43. 7.8 Anterogen
  44. 7.8.1 Anterogen Company Information
  45. 7.8.2 Anterogen Business Overview
  46. 7.8.3 Anterogen Stem Cells Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Anterogen Stem Cells Product Portfolio
  48. 7.8.5 Anterogen Recent Developments
  49. 7.9 Takeda (TiGenix)
  50. 7.9.1 Takeda (TiGenix) Company Information
  51. 7.9.2 Takeda (TiGenix) Business Overview
  52. 7.9.3 Takeda (TiGenix) Stem Cells Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Takeda (TiGenix) Stem Cells Product Portfolio
  54. 7.9.5 Takeda (TiGenix) Recent Developments
  55. 7.10 CBR
  56. 7.10.1 CBR Company Information
  57. 7.10.2 CBR Business Overview
  58. 7.10.3 CBR Stem Cells Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CBR Stem Cells Product Portfolio
  60. 7.10.5 CBR Recent Developments
  61. 7.11 ViaCord
  62. 7.11.1 ViaCord Company Information
  63. 7.11.2 ViaCord Business Overview
  64. 7.11.3 ViaCord Stem Cells Revenue and Gross Margin (2021-2026)
  65. 7.11.4 ViaCord Stem Cells Product Portfolio
  66. 7.11.5 ViaCord Recent Developments
  67. 7.12 Esperite
  68. 7.12.1 Esperite Company Information
  69. 7.12.2 Esperite Business Overview
  70. 7.12.3 Esperite Stem Cells Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Esperite Stem Cells Product Portfolio
  72. 7.12.5 Esperite Recent Developments
  73. 7.13 LifeCell
  74. 7.13.1 LifeCell Company Information
  75. 7.13.2 LifeCell Business Overview
  76. 7.13.3 LifeCell Stem Cells Revenue and Gross Margin (2021-2026)
  77. 7.13.4 LifeCell Stem Cells Product Portfolio
  78. 7.13.5 LifeCell Recent Developments
  79. 7.14 CCBC
  80. 7.14.1 CCBC Company Information
  81. 7.14.2 CCBC Business Overview
  82. 7.14.3 CCBC Stem Cells Revenue and Gross Margin (2021-2026)
  83. 7.14.4 CCBC Stem Cells Product Portfolio
  84. 7.14.5 CCBC Recent Developments
  85. 7.15 VCANBIO
  86. 7.15.1 VCANBIO Company Information
  87. 7.15.2 VCANBIO Business Overview
  88. 7.15.3 VCANBIO Stem Cells Revenue and Gross Margin (2021-2026)
  89. 7.15.4 VCANBIO Stem Cells Product Portfolio
  90. 7.15.5 VCANBIO Recent Developments
  91. 7.16 BOYA LIFE
  92. 7.16.1 BOYA LIFE Company Information
  93. 7.16.2 BOYA LIFE Business Overview
  94. 7.16.3 BOYA LIFE Stem Cells Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BOYA LIFE Stem Cells Product Portfolio
  96. 7.16.5 BOYA LIFE Recent Developments
  97. 7.17 Beike Biotechnology
  98. 7.17.1 Beike Biotechnology Company Information
  99. 7.17.2 Beike Biotechnology Business Overview
  100. 7.17.3 Beike Biotechnology Stem Cells Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Beike Biotechnology Stem Cells Product Portfolio
  102. 7.17.5 Beike Biotechnology Recent Developments
  103. 7.18 International Medical
  104. 7.18.1 International Medical Company Information
  105. 7.18.2 International Medical Business Overview
  106. 7.18.3 International Medical Stem Cells Revenue and Gross Margin (2021-2026)
  107. 7.18.4 International Medical Stem Cells Product Portfolio
  108. 7.18.5 International Medical Recent Developments
8 North America
  1. 8.1 North America Stem Cells Revenue (2021-2032)
  2. 8.2 North America Stem Cells Revenue by Type (2021-2032)
  3. 8.2.1 North America Stem Cells Revenue by Type (2021-2026)
  4. 8.2.2 North America Stem Cells Revenue by Type (2027-2032)
  5. 8.3 North America Stem Cells Revenue Share by Type (2021-2032)
  6. 8.4 North America Stem Cells Revenue by Application (2021-2032)
  7. 8.4.1 North America Stem Cells Revenue by Application (2021-2026)
  8. 8.4.2 North America Stem Cells Revenue by Application (2027-2032)
  9. 8.5 North America Stem Cells Revenue Share by Application (2021-2032)
  10. 8.6 North America Stem Cells Revenue by Country
  11. 8.6.1 North America Stem Cells Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Stem Cells Revenue by Country (2021-2026)
  13. 8.6.3 North America Stem Cells Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Stem Cells Revenue (2021-2032)
  2. 9.2 Europe Stem Cells Revenue by Type (2021-2032)
  3. 9.2.1 Europe Stem Cells Revenue by Type (2021-2026)
  4. 9.2.2 Europe Stem Cells Revenue by Type (2027-2032)
  5. 9.3 Europe Stem Cells Revenue Share by Type (2021-2032)
  6. 9.4 Europe Stem Cells Revenue by Application (2021-2032)
  7. 9.4.1 Europe Stem Cells Revenue by Application (2021-2026)
  8. 9.4.2 Europe Stem Cells Revenue by Application (2027-2032)
  9. 9.5 Europe Stem Cells Revenue Share by Application (2021-2032)
  10. 9.6 Europe Stem Cells Revenue by Country
  11. 9.6.1 Europe Stem Cells Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Stem Cells Revenue by Country (2021-2026)
  13. 9.6.3 Europe Stem Cells Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Stem Cells Revenue (2021-2032)
  2. 10.2 China Stem Cells Revenue by Type (2021-2032)
  3. 10.2.1 China Stem Cells Revenue by Type (2021-2026)
  4. 10.2.2 China Stem Cells Revenue by Type (2027-2032)
  5. 10.3 China Stem Cells Revenue Share by Type (2021-2032)
  6. 10.4 China Stem Cells Revenue by Application (2021-2032)
  7. 10.4.1 China Stem Cells Revenue by Application (2021-2026)
  8. 10.4.2 China Stem Cells Revenue by Application (2027-2032)
  9. 10.5 China Stem Cells Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Stem Cells Revenue (2021-2032)
  2. 11.2 Asia Stem Cells Revenue by Type (2021-2032)
  3. 11.2.1 Asia Stem Cells Revenue by Type (2021-2026)
  4. 11.2.2 Asia Stem Cells Revenue by Type (2027-2032)
  5. 11.3 Asia Stem Cells Revenue Share by Type (2021-2032)
  6. 11.4 Asia Stem Cells Revenue by Application (2021-2032)
  7. 11.4.1 Asia Stem Cells Revenue by Application (2021-2026)
  8. 11.4.2 Asia Stem Cells Revenue by Application (2027-2032)
  9. 11.5 Asia Stem Cells Revenue Share by Application (2021-2032)
  10. 11.6 Asia Stem Cells Revenue by Country
  11. 11.6.1 Asia Stem Cells Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Stem Cells Revenue by Country (2021-2026)
  13. 11.6.3 Asia Stem Cells Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Stem Cells Revenue (2021-2032)
  2. 12.2 SAMEA Stem Cells Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Stem Cells Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Stem Cells Revenue by Type (2027-2032)
  5. 12.3 SAMEA Stem Cells Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Stem Cells Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Stem Cells Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Stem Cells Revenue by Application (2027-2032)
  9. 12.5 SAMEA Stem Cells Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Stem Cells Revenue by Country
  11. 12.6.1 SAMEA Stem Cells Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Stem Cells Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Stem Cells Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst